Pure Global

A Study to Investigate the Pharmacokinetics of Baxdrostat When Given Alone and in Combination With Itraconazole in Healthy Participants - Trial NCT06357520

Access comprehensive clinical trial information for NCT06357520 through Pure Global AI's free database. This Phase 1 trial is sponsored by AstraZeneca and is currently Recruiting. The study focuses on Healthy Participants. Target enrollment is 14 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06357520
Phase 1
Recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06357520
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study to Investigate the Pharmacokinetics of Baxdrostat When Given Alone and in Combination With Itraconazole in Healthy Participants
An Open-label, Fixed Sequence Study in Healthy Participants to Assess the Pharmacokinetics of Baxdrostat When Administered Alone and in Combination With Itraconazole

Study Focus

Healthy Participants

Baxdrostat

Interventional

drug

Sponsor & Location

AstraZeneca

Brooklyn, United States of America

Timeline & Enrollment

Phase 1

Apr 16, 2024

Jun 06, 2024

14 participants

Primary Outcome

Area Under Plasma Concentration-Time Curve From Time Zero To Infinity (AUCinf),Maximum Observed Plasma Drug Concentration (Cmax)

Summary

The main purpose of this study is to assess the effect of itraconazole on the pharmacokinetic
 (PK) of baxdrostat.

ICD-10 Classifications

Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful
Healthy person accompanying sick person
Routine general health check-up of sports teams
Obesity
Persons with potential health hazards related to communicable diseases

Data Source

ClinicalTrials.gov

NCT06357520

Non-Device Trial